课题基金 / 基金详情

Regulation of DNA repair pathway choice during development

Regulation of DNA repair pathway choice during development
发育过程中 DNA 修复途径选择的调控
批准号:
BB/H009957/1
负责人:
Nicholas Lakin
金额:
$69.61万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --

项目摘要

项目成果

Nicholas Lakin的其他基金

相似基金

相关文献

中文摘要
翻译
遗传密码(DNA)包含一个蓝图,以产生细胞以编程方式执行其各种功能所需的所有机制。保存这些密码对维持正常的细胞功能至关重要。然而,DNA不断受到引起遗传密码变化的因子的攻击。这可能发生在细胞复制DNA(DNA复制)时,通过改变DNA构建块的序列(突变),或通过在DNA分子中产生断裂。有趣的是,DNA损伤也发生在许多正常细胞过程中的严格调控背景下,包括免疫系统的发育和遗传信息的转移,因为细胞在称为减数分裂的过程中分离其基因组。因此,细胞已经开发出一个复杂的途径网络,以检测DNA损伤,并通过DNA修复来纠正这些错误。DNA修复的重要性被以下观察结果所强调:这些途径中的缺陷导致各种使人衰弱的临床症状,包括过早衰老、免疫系统衰竭、发育异常和癌症风险增加。因此,了解DNA修复将提供洞察几个基本的生物过程,除了关于一些疾病状态的分子基础的线索。DNA双螺旋的两条链的断裂(双链断裂; DSB)是DNA损伤中毒性最大的种类之一。这些可以通过直接重新连接DNA断裂(非同源末端连接; NHEJ)或通过使用同源DNA作为模板来恢复基因组完整性(同源定向修复; HDR)来修复。这两种途径的组分已充分表征。然而,影响细胞是否通过NHEJ或HDR修复损伤的因素仍然相对不明确。DNA修复缺陷会导致多种发育异常,包括抗体产生缺陷、颅面畸形和神经系统退化。尽管如此,当多细胞生物体发育成各种专门的组织时,这些途径如何被调节仍然在很大程度上未被探索。从细菌到人类,所有生物体都通过类似的机制实现DNA修复。因此,在相对简单的模式生物中研究这些途径增加了我们对这些过程在人类中如何工作的理解。不幸的是,某些常用的模式生物缺乏人类DNA DSB修复途径的关键组分,并且不经历发育程序成为专门的细胞类型。相比之下,土壤中的阿米巴Dictyosteoba是一种容易生长和操纵的生物体,经历了一个相对简单的发育程序。因此,它是研究细胞类型特化和分化的常用模型。此外,我们以前的工作已经表明,在这种生物体中的DNA DSB修复途径比其他常用的模式生物更类似于人类。本研究的目的是利用这些观察结果,并使用Dictyosteopathy作为模型来研究DNA DSB修复途径的选择是如何在生物体的生命周期和发育程序的背景下进行调节。除了提供有关DNA修复途径如何在网骨藻中调节的见解外,这些研究可能适用于这些过程如何在包括人类在内的其他高等生物中实现。
英文摘要
The genetic code (DNA) contains a blueprint to produce all the machinery required for a cell to perform its various functions in a programmed manner. Preservation of this code is critical to maintain normal cellular functions. However, DNA is under continual attack from agents that cause changes in the genetic code. This can occur when cells copy their DNA (DNA replication), through changes in the sequence of DNA building blocks (mutation), or by creating breaks in the DNA molecule. Interestingly, DNA damage also occurs in a tightly regulated context during a number of normal cellular processes including development of the immune-system and transfer of genetic information as cells segregate their genomes in a process know as meiosis. Therefore, cells have developed a complex network of pathways to detect DNA damage when it occurs and correct these faults by DNA repair. The importance of DNA repair is underscored by the observations that defects in these pathways leads to a variety of debilitating clinical symptoms including premature ageing, immune-system failure, developmental abnormalities and increased cancer risk. Therefore, understanding DNA repair will provide insights into several fundamental biological processes in addition to clues regarding the molecular basis of a number of disease states. Breaks in both strands of the DNA double helix (double strand breaks; DSBs) are one of the most toxic varieties of DNA damage. These can be repaired by directly re-joining DNA breaks (non-homologous end-joining; NHEJ), or by using homologous DNA as a template to restore genome integrity (homology-directed repair; HDR). The components of these two pathways are well characterised. However, the factors that influence whether cells repair damage by NHEJ or HDR remains relatively ill defined. Defects in DNA repair lead to a variety of developmental abnormalities including defective antibody production, cranial-facial abnormalities and degeneration of the nervous system. Despite this, how these pathways are regulated as multi-cellular organisms develop into a variety of specialised tissues remains largely unexplored. DNA repair is achieved by similar mechanisms in all organisms from bacteria to humans. Therefore, studying these pathways in relatively simple model organisms has increased our understanding of how these processes work in humans. Unfortunately, certain commonly used model organisms lack key components of human DNA DSB repair pathways and do not undergo a developmental program into specialised cell types. In contrast, the soil dwelling amoeba Dictyostelium is an easily grown and manipulated organism that undergoes a relatively simple developmental program. As such, it is a commonly used model to study cell type specification and differentiation. In addition, our previous work has illustrated that DNA DSB repair pathways in this organism are more similar to humans than other commonly used model organisms. The aims of this research are to exploit these observations and use Dictyostelium as a model to study how DNA DSB repair pathway choice is regulated in the context of an organism's life cycle and developmental program. In addition to providing insights into how DNA repair pathways are regulated in Dictyostelium, these studies will likely be applicable to how these processes are achieved in other higher organisms including humans.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/978-1-62703-302-2_16
发表时间: 2013-01-01
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Couto, Anne-Marie C, Lakin, Nicholas D, Pears, Catherine J]
通讯作者: Pears, Catherine J
PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks.
PARP通过在双链断裂中保留KU来调节非同源末端。
DOI: 10.1083/jcb.201012132
发表时间: 2011-08-08
期刊: The Journal of cell biology
影响因子: --
作者: [Couto CA, Wang HY, Green JC, Kiely R, Siddaway R, Borer C, Pears CJ, Lakin ND]
通讯作者: Lakin ND
Emerging models for DNA repair: Dictyostelium discoideum as a model for nonhomologous end-joining.
DNA 修复的新兴模型:盘基网柄菌作为非同源末端连接的模型。
DOI: 10.1016/j.dnarep.2014.01.008
发表时间: 2014
期刊: DNA repair
影响因子: 3.8
作者: [Pears CJ]
通讯作者: Pears CJ
Regulation of DNA repair by histone ADP-ribosylation
  • 批准号:
    MR/W017350/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $86.32万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Lakin
  • 依托单位:
Defining the role of PARPs in the DNA repair and genome stability
  • 批准号:
    MR/V00896X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $102.01万
  • 财政年份:
    2021
  • 负责人:
    Nicholas Lakin
  • 依托单位:
Defining the role of ADP-ribosyltransferases in DNA repair and genome stability
  • 批准号:
    MR/P018963/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $50.37万
  • 财政年份:
    2017
  • 负责人:
    Nicholas Lakin
  • 依托单位:
Defining the function of histone ADP-ribosylation in DNA repair and genome integrity
  • 批准号:
    MR/P028284/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.29万
  • 财政年份:
    2017
  • 负责人:
    Nicholas Lakin
  • 依托单位:
国内基金
海外基金
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
  • 批准号:
    82371607
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    李铮
  • 依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
PHF19上调EXD2促进DNA损伤修复增加胶质瘤放疗抵抗的作用与机制研究
  • 批准号:
    32100591
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    何江
  • 依托单位:
STRIPAK复合物调控DNA损伤修复及肠癌化疗耐药的功能与机制研究
  • 批准号:
    32070710
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    安利伟
  • 依托单位: